PR Newswire Asia
ZEISS showcases next-level eye care digitalization at AAO 2019
Sat, 12 Oct 2019 22:00:00 +0800
Indonesia's Largest Single-payer System BPJS Kesehatan Teams up with Local Health Apps Startup Halodoc to Improve Equal Access to Health Care Across the Country
Fri, 11 Oct 2019 20:35:00 +0800
CMAB Biopharma and BJ Bioscience Establish an Exclusive Strategic Partnership
Fri, 11 Oct 2019 18:00:00 +0800
Kangpu Biopharmaceuticals Successfully Completed Phase I Study of Novel CRL4-CRBN Modulator KPG-818 in the U.S.
Fri, 11 Oct 2019 13:00:00 +0800
Bayer G4A Partners With Wellthy Therapeutics
Fri, 11 Oct 2019 09:00:00 +0800
WuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast New Chemical Space of Tangible Molecules
Fri, 11 Oct 2019 08:02:00 +0800
Caliber Ophthalmics Introduces Sharpoint Edge CC3D Plus Product Line at AAO in San Francisco
Thu, 10 Oct 2019 22:09:00 +0800
MabPlex Lauded by Frost & Sullivan for Global Expansion of ADC Contract Manufacturing Services
Thu, 10 Oct 2019 21:00:00 +0800
111 Unveils New Video on What the Internet Could Do for the Health Management of Aging
Thu, 10 Oct 2019 20:31:00 +0800
Saudi Ministry of Health Provides More Accessible Health Services Through Its "937 Call Center"
Thu, 10 Oct 2019 18:30:00 +0800
Innovent and Chi-Med Expand Global Collaboration to Evaluate the Combination of Sintilimab and Surufatinib in Solid Tumors
Thu, 10 Oct 2019 15:55:00 +0800
Path-breaking Study Reports High Sensitivity in Diabetic Retinopathy Screening Using Smartphones and Automated-AI in Primary-Care: Remidio Innovative Solutions
Thu, 10 Oct 2019 11:34:00 +0800
Volition Appoints Dr. Phillip Barnes to Board of Directors
Thu, 10 Oct 2019 04:05:00 +0800
CTFH and Insilico Medicine Enter Al Drug Discovery Collaboration Focused On Accelerating First-in-Class Therapeutics, Worth Up to $200 million
Wed, 09 Oct 2019 20:58:00 +0800
BlueBee Establishes Data Center in Mainland China, Expanding Global Coverage for Its Genomics Data Platform
Wed, 09 Oct 2019 20:00:00 +0800
Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protocol in the RESILIENT Trial
Wed, 09 Oct 2019 17:56:00 +0800
World Thrombosis Day Empowers People Around the World to Recognize and Help Prevent Life-Threatening Blood Clots
Wed, 09 Oct 2019 12:00:00 +0800
Tim Oldham Appointed as Chief Executive Officer of AdAlta Ltd
Wed, 09 Oct 2019 09:42:00 +0800
Breast Cancer: Hormone Therapy Has a Bigger Impact Than Chemotherapy on Women's Quality of Life - Research by Institut Gustave Roussy
Wed, 09 Oct 2019 07:00:00 +0800
Precision Diabetes, LLC, Presents Data on Novel, Predictive Tests for Diabetes Complications at American Diabetes Association (ADA) Research Symposium: Advancing Precision Diabetes Medicine
Tue, 08 Oct 2019 20:30:00 +0800

rssfeedwidget.com